Proceedings of the National Academy of Sciences · 1979 · 204 citations · 25 references
MedicineBiochemistryPharmacologyBiochemical PharmacologyDrug MetabolismMetabolismAnalgesic PharmacologyAnti-inflammatory PharmacologyEicosanoid BiosynthesisLipid Metabolism5-Lipoxygenase InhibitionArachidonic Acid MetabolitesCyclooxygenase PathwaysLipoxygenase InhibitionLipoxygenase PathwayOxidoreductase EnzymesProstaglandin Synthesis InhibitionSalicylate Metabolism
Aspirin, indomethacin, and sodium salicylate are anti-inflammatory, analgesic, and antipyretic. Whereas aspirin and indomethacin inhibit prostaglandin synthetase (cyclo-oxygenase; 8,11,14-eicosatrienoate, hydrogen-donor: oxygen oxidoreductase, EC 1.14.99.1), salicylate does not. However, all three drugs affect the metabolism of arachidonate via the lipoxygenase pathway by inhibiting the conversion of 12-hydroperoxy- to 12-hydroxy-5,8,10,14-eicosatetraenoic acid.
25